JMP Securities Starts Prelude Therapeutics (PRLD) at Market Outperform, 'Precision Targeting of SMARCA Drives Cell Kill'

Go back to JMP Securities Starts Prelude Therapeutics (PRLD) at Market Outperform, 'Precision Targeting of SMARCA Drives Cell Kill'
(NASDAQ: PRLD) Delayed: 5.55 +0.19 (3.54%)
Previous Close $5.36    52 Week High
Open $5.45    52 Week Low
Day High $5.61    P/E N/A 
Day Low $5.15    EPS
Volume 452,124